These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24750386)

  • 21. BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance.
    Vandermeulen E; Verleden SE; Ruttens D; Moelants E; Mortier A; Somers J; Bellon H; Piloni D; Dupont LJ; Van Raemdonck DE; Proost P; Schols D; Vos R; Verleden GM; Vanaudenaerde BM
    Transpl Immunol; 2015 Sep; 33(1):37-44. PubMed ID: 26168736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
    Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF
    Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
    Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
    Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilatory capacity in CLAD is driven by dysfunctional airway structure.
    Kerckhof P; Ambrocio GPL; Beeckmans H; Kaes J; Geudens V; Bos S; Willems L; Vermaut A; Vermant M; Goos T; De Fays C; Aversa L; Mohamady Y; Vanstapel A; Orlitová M; Van Slambrouck J; Jin X; Varghese V; Josipovic I; Boone MN; Dupont LJ; Weynand B; Dubbeldam A; Van Raemdonck DE; Ceulemans LJ; Gayan-Ramirez G; De Sadeleer LJ; McDonough JE; Vanaudenaerde BM; Vos R
    EBioMedicine; 2024 Mar; 101():105030. PubMed ID: 38394744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Transplant Body Mass Index and Post-Transplant Weight Changes on the Development of Chronic Lung Allograft Dysfunction Phenotypes.
    Beauchamp-Parent C; Jomphe V; Morisset J; Poirier C; Lands LC; Nasir BS; Ferraro P; Mailhot G
    Transplant Proc; 2024; 56(6):1420-1428. PubMed ID: 38991901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
    Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
    Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel model for dissecting roles of IL-17 in lung transplantation.
    Chen R; Liang F; Chen Q; Xu J; Ding Y
    J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
    Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
    Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
    McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.